Literature DB >> 11773631

Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.

Bernard C Broughton1, Agnes Cordonnier, Wim J Kleijer, Nicolaas G J Jaspers, Heather Fawcett, Anja Raams, Victor H Garritsen, Anne Stary, Marie-Françoise Avril, Francois Boudsocq, Chikahide Masutani, Fumio Hanaoka, Robert P Fuchs, Alain Sarasin, Alan R Lehmann.   

Abstract

Xeroderma pigmentosum variant (XP-V) cells are deficient in their ability to synthesize intact daughter DNA strands after UV irradiation. This deficiency results from mutations in the gene encoding DNA polymerase eta, which is required for effecting translesion synthesis (TLS) past UV photoproducts. We have developed a simple cellular procedure to identify XP-V cell strains, and have subsequently analyzed the mutations in 21 patients with XP-V. The 16 mutations that we have identified fall into three categories. Many of them result in severe truncations of the protein and are effectively null alleles. However, we have also identified five missense mutations located in the conserved catalytic domain of the protein. Extracts of cells falling into these two categories are defective in the ability to carry out TLS past sites of DNA damage. Three mutations cause truncations at the C terminus such that the catalytic domains are intact, and extracts from these cells are able to carry out TLS. From our previous work, however, we anticipate that protein in these cells will not be localized in the nucleus nor will it be relocalized into replication foci during DNA replication. The spectrum of both missense and truncating mutations is markedly skewed toward the N-terminal half of the protein. Two of the missense mutations are predicted to affect the interaction with DNA, the others are likely to disrupt the three-dimensional structure of the protein. There is a wide variability in clinical features among patients, which is not obviously related to the site or type of mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773631      PMCID: PMC117388          DOI: 10.1073/pnas.022473899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity.

Authors:  C Masutani; M Araki; A Yamada; R Kusumoto; T Nogimori; T Maekawa; S Iwai; F Hanaoka
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  A plethora of lesion-replicating DNA polymerases.

Authors:  R Woodgate
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

3.  hRAD30 mutations in the variant form of xeroderma pigmentosum.

Authors:  R E Johnson; C M Kondratick; S Prakash; L Prakash
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

4.  Xeroderma pigmentosum variant: generation and characterization of fibroblastic cell lines transformed with SV40 large T antigen.

Authors:  S A King; S J Wilson; R A Farber; W K Kaufmann; M Cordeiro-Stone
Journal:  Exp Cell Res       Date:  1995-03       Impact factor: 3.905

5.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta.

Authors:  C Masutani; R Kusumoto; A Yamada; N Dohmae; M Yokoi; M Yuasa; M Araki; S Iwai; K Takio; F Hanaoka
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

6.  Mechanisms of accurate translesion synthesis by human DNA polymerase eta.

Authors:  C Masutani; R Kusumoto; S Iwai; F Hanaoka
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

7.  A simple method for diagnosing xeroderma pigmentosum variant.

Authors:  T Itoh; T Ono; M Yamaizumi
Journal:  J Invest Dermatol       Date:  1996-09       Impact factor: 8.551

8.  Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation.

Authors:  T Itoh; S Linn; R Kamide; H Tokushige; N Katori; Y Hosaka; M Yamaizumi
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

9.  Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene.

Authors:  M Yuasa; C Masutani; T Eki; F Hanaoka
Journal:  Oncogene       Date:  2000-09-28       Impact factor: 9.867

Review 10.  Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription.

Authors:  M Berneburg; A R Lehmann
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

View more
  51 in total

1.  A novel POLH gene mutation in a xeroderma pigmentosum-V Tunisian patient: phenotype-genotype correlation.

Authors:  Mariem Ben Rekaya; Olfa Messaoud; Amel Mebazaa; Olfa Riahi; Hela Azaiez; Rim Kefi; Mohamed Zghal; Samir Boubaker; Ahlem Amouri; Amel Ben Osman-Dhahri; Sonia Abdelhak; Mourad Mokni
Journal:  J Genet       Date:  2011-12       Impact factor: 1.166

2.  Diagnosis of Xeroderma Pigmentosum and Related DNA Repair-Deficient Cutaneous Diseases.

Authors:  James E Cleaver
Journal:  Curr Med Lit Dermatol       Date:  2008

Review 3.  [Light protection for xeroderma pigmentosum].

Authors:  M Ettinger; M Berneburg
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

4.  Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.

Authors:  Jennifer Boyle; Takahiro Ueda; Kyu-Seon Oh; Kyoko Imoto; Deborah Tamura; Jared Jagdeo; Sikandar G Khan; Carine Nadem; John J Digiovanna; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2008-10       Impact factor: 4.878

Review 5.  Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.

Authors:  Hema L Ramkumar; Brian P Brooks; Xiaoguang Cao; Deborah Tamura; John J Digiovanna; Kenneth H Kraemer; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 6.048

6.  Escherichia coli nucleoside diphosphate kinase mutants depend on translesion DNA synthesis to prevent mutagenesis.

Authors:  Jared Nordman; Andrew Wright
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

7.  DNA polymerase η is regulated by poly(rC)-binding protein 1 via mRNA stability.

Authors:  Cong Ren; Seong-Jun Cho; Yong-Sam Jung; Xinbin Chen
Journal:  Biochem J       Date:  2014-12-15       Impact factor: 3.857

8.  Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.

Authors:  Nils H Nicolay; Rebecca Carter; Stephanie B Hatch; Niklas Schultz; Remko Prevo; W Gillies McKenna; Thomas Helleday; Ricky A Sharma
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

9.  Structure and mechanism of human DNA polymerase eta.

Authors:  Christian Biertümpfel; Ye Zhao; Yuji Kondo; Santiago Ramón-Maiques; Mark Gregory; Jae Young Lee; Chikahide Masutani; Alan R Lehmann; Fumio Hanaoka; Wei Yang
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

Review 10.  Xeroderma Pigmentosum.

Authors:  Jennifer O Black
Journal:  Head Neck Pathol       Date:  2016-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.